What does this research cover?
The Dairy Alternatives research brief covers alternatives to dairy across beverages, cultured products and other agreed applications. Geographic coverage: Global. The scope combines plant bases, usage occasions and price positioning with downside, reference and upside conditions. The question: where to compete, and what evidence would justify investment?
Where does the market begin and end?
Define the included applications before comparing this umbrella category with plant-based milk or dairy-free desserts. The analytical lens is product stage, formulation, household occasion and channel. A commissioned scope fixes product inclusions, customer groups, countries, sales channels and the reference period before sizing begins. Value and volume measures remain separate. Where categories overlap, the model records the relationship rather than adding the same activity twice. Global coverage requires explicit country coverage and does not imply equally detailed evidence everywhere.
| Decision variable | Downside | Reference | Upside |
|---|---|---|---|
| Repeat substitution | Repeat adoption weakens | Repeat adoption holds | Repeat adoption strengthens |
| Formulation economics | Input pressure rises | Input pressure stabilises | Input pressure eases |
| Refrigerated shelf access | Shelf access contracts | Shelf access holds | Shelf access broadens |
Which conditions change the decision?
The scenario matrix follows three decision variables: repeat substitution, formulation economics, refrigerated shelf access. Downside conditions test resilience when adoption or access weakens and economics become less favourable. The reference pathway holds the stated operating conditions steady; it is not a claim about the most probable outcome. Upside conditions examine what additional adoption, access or efficiency would need to occur. The matrix defines conditions to investigate, not measured market movements or assigned probabilities.
Economics under pressure
ProtectReassess exposure, cost and commitments.
Repeatability evidenced
ValidateTest the proposition before scaling.
Expansion milestones met
ExpandRelease investment against evidence.
How is the evidence assessed?
Our research approach prioritises official production and trade series, company category disclosures, dated retail assortments and product specifications. Source dates, definitions and geographic coverage establish what each input can support. Independent sources are compared on a consistent basis; repeated versions of the same estimate count as one evidence source. Product definitions, age stages where relevant, cold-chain requirements and pack sizes need consistent treatment. Brand presence cannot establish category share, and household interest cannot substitute for purchase evidence. Forecasts distinguish the observed starting point from assumptions about future demand, pricing and supply. The supporting calculations make those relationships traceable.
How should scenarios inform action?
The decision pathways connect conditions to actions: protect economics under pressure, validate repeatability under reference conditions, and release expansion investment when upside milestones are evidenced. These are options to evaluate, not automatic recommendations. A market-entry decision also needs company-specific capabilities, economics and risk tolerances. The useful question is which observation would change the decision, how soon it can be collected, and whether the cost of waiting is greater than the cost of acting.
What is included in an engagement?
Agree the geography, research questions, evidence requirements, delivery date and licence before commissioning. The engagement can combine a concise report, an evidence workbook and an analyst briefing. Researchers own the methodology, assumptions, source evaluation and final review; AI assists organisation and production. Interviews, surveys and licensed datasets are scoped separately where needed.